Contracts in Clinical Trials: Which Documents Govern Collaboration Between Parties?
Conducting a clinical trial requires not only preparing medical and regulatory documentation but also concluding appropriate contracts among all parties involved in the project. Contracts define the scope of responsibilities, funding rules, data transfer procedures, organizational duties, and the terms of cooperation between the sponsor, site, investigator, and other entities participating in the study.
A key type of contract is the agreement between the sponsor and the CRO, the organization conducting the clinical trial on behalf of the sponsor. This document specifies the tasks delegated to the CRO, such as study coordination, site communication, monitoring, document management, management of study systems, safety reporting, and regulatory support. The sponsor–CRO agreement should clearly outline the division of responsibilities, communication rules, quality requirements, timelines for individual tasks, and the method of reporting study progress.
At the operational level, a fundamental document is the clinical trial agreement (CTA), usually concluded between the sponsor or CRO and the research site and principal investigator. This agreement defines, among other things, the site’s responsibilities, protocol execution rules, remuneration, reporting procedures, documentation requirements, confidentiality obligations, and the parties’ liabilities.
In practice, agreements are also made with the principal investigator and often with other study team members if their involvement requires separate arrangements. Such agreements may cover performing medical procedures, managing documentation, overseeing study participants, or participating in monitoring visits.
Another important element is a data processing agreement or provisions regarding data protection. Clinical trials involve handling participant data, so it is essential to precisely define the roles of the parties, security rules, the scope of data processing, and obligations arising from data protection regulations.
Depending on the nature of the project, additional agreements may be required, e.g., with the central laboratory, subcontractors, logistics service providers, document archiving companies, eCRF/eTMF system providers, translation services, monitoring teams, investigational product management, or diagnostic services. Each contract should clearly specify the scope of work, deadlines, responsibilities, confidentiality, and payment terms.
Contracts in clinical trials are critical for the legal and organizational security of the entire project. Well-prepared contractual documentation helps avoid ambiguities, facilitates collaboration between parties, and supports proper execution of the study in accordance with the protocol, sponsor requirements, and applicable quality standards.
